1Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus in -fection in subjects without hepatitis B surface antigen:clinically signifi - cant of purely" occult" ? [ J ]. Hepatology, 2001,34 (1) :194 -203.
2CacciolaI, PollicinOT, SquadritOC, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [ J ]. N Engl J Med,1999,341:22 -26.
3Dow BC, Peterkin MA, Green RH, et al. Hepatitis B virus transmission by blood donation negative for hepatitis Bsurface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA [ J]. Vox Sang,2001,81 : 140.
1Busch MP,Rawal BD,Nowicki M,et al.HCV RNA and ALT patterns in seroconverting transfusion recipients and correlation with donor ALT and RNA[].Transfusion.1997
2Vrielink H,Reesink HW,van den Burg PJM,et al.Performance of three generations of anti-hepatitis C virus ELISA in donors and patients[].Transfusion.1997
3Schottstedt V,Tuma W,Bunger G,et al.PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service[].Biologicals.1998
4Schreiber GB,Busch MP,Kleinman SH,et al.The risk of transfusiontransmitted viral infection[].The New England Journal of Medicine.1996
5Roth WK,Weber M,Seifried E.Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting[].The Lancet.1999
6Cardoso MS,Koerner K,Kubanek B,et al.Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results[].Transfusion.1998
